导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | 0.16% | 544/1050 |
| 近一周 | -1.97% | 392/1104 |
| 近一月 | -3.29% | 387/1102 |
| 近一季 | -6.84% | 512/1092 |
| 近半年 | -8.36% | 715/1070 |
| 近一年 | 6.69% | 431/1018 |
| 近两年 | 46.92% | 523/926 |
| 近三年 | 30.32% | 392/834 |
| 成立以来 | 205.02% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
3.30% 244/1070 |
3.84% 633/1101 |
- - |
- - |
| 2025 | 23.44% 610/1065 |
1.97% 650/1014 |
-1.30% 799/1038 |
21.11% 576/1050 |
1.27% 369/1065 |
| 2024 | 11.81% 246/1011 |
2.58% 182/960 |
-0.12% 315/983 |
12.41% 425/991 |
-2.92% 530/1011 |
| 2023 | -17.89% 619/952 |
-2.00% 714/880 |
-3.35% 406/895 |
-8.52% 530/915 |
-5.23% 536/952 |
| 2022 | -13.59% 144/867 |
-15.85% 302/773 |
12.43% 179/806 |
-9.19% 200/845 |
0.59% 420/867 |
| 2021 | 21.22% 150/740 |
-9.02% 469/580 |
19.49% 167/659 |
5.93% 110/704 |
5.26% 212/740 |
| 2020 | 65.82% 161/554 |
2.17% 110/419 |
27.86% 147/466 |
13.94% 164/517 |
11.41% 313/554 |
| 2019 | 63.79% 64/410 |
25.68% 652/1149 |
2.17% 157/1231 |
16.96% 29/390 |
9.06% 188/410 |
| 2018 | -20.58% 89/349 |
- - |
- - |
- - |
-12.34% 637/1080 |
| 2017 | 1.82% 169/285 |
- - |
- - |
- - |
- - |
| 2016 | -15.18% 94/205 |
- - |
- - |
- - |
- - |
| 2015 | - - |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 招商前沿医疗保健股票A | 0.8511 | 59.95% |
| 招商前沿医疗保健股票C | 0.8165 | 53.69% |
| 招商医药健康产业股票 | 2.6450 | 48.73% |
| 前海开源公共卫生股票A | 0.4748 | 42.37% |
| 广发医药精选股票A | 1.3315 | 41.03% |
| 嘉实医疗保健股票 | 2.6190 | 39.05% |
| 广发医药精选股票C | 1.3103 | 38.32% |
| 前海开源公共卫生股票C | 0.4647 | 37.30% |
| 交银医药创新股票A | 2.9144 | 36.05% |
| 交银医药创新股票C | 3.0948 | 35.86% |
| 南方国策动力 VS. 东吴新产业精选股票A(580008) |